Cardiovascular Digital Solutions Market size is estimated at USD 101.7 billion in 2024 and is likely to exceed USD 211.7 billion by the end of 2037, growing at over 6.3% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of cardiovascular digital solutions is evaluated at USD 108.1 billion.
The market is driven by growing morbidity due to cardiovascular diseases (CVDs), advancements in telehealth, and an increasing demand for more personalized patient care. According to the World Health Organization (WHO) statistics, CVDs are a leading cause of death and accounted for 32% of global deaths in 2019. This compelling statistic sparks unique approaches to diagnosis, monitoring, and managing cardiovascular health. The increased usage of telemedicine, technological advancement of wearable devices, AI-driven analytics, and integration of digital health records are the growth drivers that enhance healthcare accessibility and improve clinical outcomes.
As the stakeholders increasingly discover the reliability of these solutions, cardiovascular digital solutions market growth witnesses robust support for that transformational shift in cardiovascular care delivery. The adoption of telehealth solutions has drastically increased, with a focus on advanced remote patient monitoring (RPM) systems. For instance, in February 2021, Remo Care Solutions announced the launch of Remo.Cardo, a remote cardiac monitoring device equipped with AI that monitors and accesses heart health in real time.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.3% |
|
Base Year Market Size (2024) |
USD 101.7 billion |
|
Forecast Year Market Size (2037) |
USD 211.7 billion |
|
Regional Scope |
|
Component (Devices, Software)
Devices segment is likely to account for around 58.7% cardiovascular digital solutions market share by 2037, owing to the increasing uptake of wearable technology, remote monitoring technologies, and the need for continuous, real-time health data. Continued advancements in technology and increased health consciousness are contributing to this growth. In August 2024, GE Healthcare announced the CE mark of its Vscan Air SL wireless handheld ultrasound solution for rapid cardiac assessment.
Application (Cardiac monitoring and diagnosis, CVD health informatics, Cardiac rehab programs)
By 2037, cardiac monitoring and diagnosis segment is set to capture over 57.1% cardiovascular digital solutions market share, owing to growing incidence rates of CVDs, increased use of remote patient monitoring, and constant improvements in wearable technology. The growth of this segment is brought about by new developments in wearable devices such as smartwatches and patch monitors, which enable the tracking of heart rates, ECG, and blood pressure. In March 2024, Wellysis partnered with Arthella Solutions to launch innovative remote monitoring services for cardiac health in the U.S.
Our in-depth analysis of the cardiovascular digital solutions market includes the following segments:
|
Component |
|
|
Application |
|
|
Deployment Mode |
|
|
End use |
|
North America Market Statistics
North America cardiovascular digital solutions market is predicted to hold revenue share of over 33.2% by the end of 2037, owing to the rising prevalence of cardiac diseases, the presence of well-developed healthcare infrastructure, and increasing product launches and approvals for cardiovascular health.
The U.S. market is expected to expand at a robust rate during the forecast period. According to statistics released by the Centers for Disease Control and Prevention, CVD accounted for 37% of all deaths in the U.S. in 2021. With an emphasis on preventive care and shifting healthcare approaches towards a more preventive course, the need for sophisticated digital technologies has increased to monitor and track patients, advance early diagnosis, and reinforce the efficiency of treatments in the U.S.
In Canada, the cardiovascular digital solutions market is poised to register rapid growth between 2025 and 2037 owing to the rising incidence of heart diseases and increasing adoption of advanced digital healthcare. Companies are also focusing on developing advanced products and digital solutions for cardiac care. For instance, CIFAR launched two AI health solutions to cater to rising health problems in Canada, including cardiovascular diseases.
Asia Pacific Market Analysis
Asia Pacific cardiovascular digital solutions market is expected to expand at a robust CAGR during the forecast period owing to rising prevalence of cardiovascular diseases, hypertension, and diabetes, the high adoption of unhealthy lifestyles, and the rapid adoption of advanced cardiovascular digital solutions across several healthcare sectors. Moreover, the integration of AI, ML, and telemedicine in cardiovascular care solutions is expected to further accelerate market growth in the Asia Pacific.
In India, the cardiovascular digital solutions market is expected to register a rapid revenue CAGR between 2025 and 2037. This growth can be attributed to the high prevalence of heart diseases, rapid adoption of advanced healthcare technologies, and rising awareness about the importance of early detection and diagnosis. Companies are also investing in R&D investments to launch novel and effective cardiovascular digital solutions. In January 2023, Lupin Digital Health announced the launch of LYFE, a digital therapeutic solution for heart care. This solution is currently available in 10 cities, designed to reduce the risk of heart disease and enhance the quality of life of patients.
The cardiovascular digital solutions market in China is anticipated to expand at a rapid growth during the forecast period owing to the presence of robust healthcare infrastructure, rising prevalence of various cardiovascular diseases, and rising investments in R&D activities. For instance, in April 2020, Novartis launched a novel AI-enabled disease management tool in China to improve the rate of heart failure in the country.
Diverse companies, from the leading giants in the healthcare sector to the startup entities, are taking a leading role in this competition to advance the most innovative solutions that benefit patients with better outcomes in healthcare delivery. The major players in the region of these settings are focusing on implementing artificial intelligence, wearable devices, and data analytics for an effective resolution of chronic cardiovascular conditions. With these innovations, regulatory frameworks are constantly in motion, and landscapes transform themselves into something dynamic in a manner that opens vast growth opportunities for businesses fully committed to changing cardiovascular care with digital technology. Here is a list of key players operating in the global market:
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?